Antagonizing P2Y12 Receptor Inhibitors: Current and Future Options.
Sign Up to like & getrecommendations! Published in 2019 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0039-1693738
Abstract: There are clinical scenarios where the balance between the risk of ischemic and bleeding events leads to the clinical decision to reverse the antiplatelet effect of P2Y12 receptor inhibitors. These scenarios comprise emergency situations such… read more here.
Keywords: administration; antagonizing p2y12; receptor inhibitors; effect ... See more keywords